The BRUIN CLL-322 trial evaluated the safety and efficacy of pirtobrutinib plus venetoclax and rituximab in previously treated CLL/SLL patients.
Understanding the diagnosis and treatment options empowered the patient, fostering a sense of control and preparedness. Maintaining a positive mental attitude and aligning with supportive healthcare ...
Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) are types of slow-growing cancers that affect a type of white blood cell called a lymphocyte. Lymphocytes are cells that help ...
Pirtobrutinib was associated with a statistically significant improvement in PFS compared with bendamustine plus rituximab therapy. Topline data were announced from a phase 3 trial evaluating ...
The Food and Drug Administration’s approval of Calquence (acalabrutinib) for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma offers an exciting treatment option, ...
© 2026 Forbes Media LLC. All Rights Reserved.
© 2026 Forbes Media LLC. All Rights Reserved.
Wednesday 22 April 2026 1 SLL = 0.0044732 INR 0.0044666 0.0044753 SLL INR rate for 22/04/2026 Tuesday 21 April 2026 1 SLL = 0.0044647 INR 0.0044537 0.0044555 SLL INR rate for 21/04/2026 Monday 20 ...
Wednesday 22 April 2026 1 EUR = 24548 SLL 24600 24598 EUR SLL rate for 22/04/2026 Tuesday 21 April 2026 1 EUR = 24618 SLL 24638 24679 EUR SLL rate for 21/04/2026 Monday 20 April 2026 1 EUR = 24720 SLL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results